By Ella Devereux2026-07-09T12:00:00
Patients with lung disease suffered harm or died after treatment was repeatedly delayed or replaced with alternatives which had no evidence base, an independent review has found.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud